Angiotensin II and its receptors in the diabetic kidney.
about
The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study.Diabetes mellitus and its chronic complications.Genetic Predisposition to Diabetic Nephropathy: Evidence for a Role of ACE (I/D) Gene Polymorphism in Type 2 Diabetic Population from Kutch RegionAngiotensin II and the glomerulus: focus on diabetic kidney disease.Appropriate drug therapy for improving outcomes in diabetic nephropathy.Angiotensin receptor blockers in diabetic nephropathy.Benazepril affects integrin-linked kinase and smooth muscle α-actin expression in diabetic rat glomerulus and cultured mesangial cells.Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing HemodialysisTesting for microalbuminuria and albuminuria in diabetes should be as important as checking blood pressure.Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT(1) Receptor in Renal and Hepatic Tissues of Streptozotocin-Induced Diabetic RatsMedaka fish, Oryzias latipes, as a model for human obesity-related glomerulopathy.The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus.Enalapril treatment restores the decreased proximal tubule reabsorption in response to acute volume expansion in diabetic ratsDecreased renal AT1 receptor binding in rats after subtotal nephrectomy: PET study with [(18)F]FPyKYNE-losartanNovel mechanisms of protein synthesis in diabetic nephropathy--role of mRNA translation.Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study.Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy.Blood pressure and renal hemodynamic effects of angiotensin fragments.Reduced IP receptors in STZ-induced diabetic rat kidneys and high-glucose-treated mesangial cells.Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells.Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.Association between the Angiotensin-Converting Enzyme (ACE) Genetic Polymorphism and Diabetic Retinopathy-A Meta-Analysis Comprising 10,168 Subjects.Signaling cascade of ANG II-induced inhibition of alpha-MG uptake in renal proximal tubule cells.Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy.Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.[Molecular bases of diabetic nephropathy].Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes.Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice.Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects.Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
P2860
Q30310671-90AF0979-7593-4197-A45B-3786D60EFFEDQ33281856-4158E946-62D0-4196-8BE3-4D14A7998F44Q33608656-9649E65C-4317-4D88-AF8D-31D2A3C176C3Q34483554-5B4D4DC3-A161-4329-B607-79D7AF677FE8Q34795600-EC12689E-8A43-4050-A15F-58C6A360F385Q35028043-81D0CF01-86A5-4975-A0F6-B56921E3E1A3Q35087034-5A6C44B3-B3D8-43B5-AD5D-42AFB6ACB38CQ35087535-DE9D5193-0EAA-4795-9064-BA70331DD033Q35087684-6B9497CD-6A97-4C52-B073-E9A12C28D34BQ35228907-E00B3D42-5358-43F8-A483-03A3C4E0DA84Q35972437-10ED3FDF-1D13-45AF-AAF7-18DD076FA3D5Q36072276-0D5BF23C-BED1-49A3-8CF0-753B21F906D2Q36457460-4639B4C4-9BD5-4AFC-9145-A180AC6C0698Q36654960-2A8E8AE3-CE3B-410F-8BDA-D6CD87CDB864Q36909521-B6CBDC70-2F3B-4326-BA81-9461082910EEQ36942996-59A2C184-B47E-4CDB-8F32-287CDC30E887Q37033868-C2EDDA72-A3F6-4E27-904A-0D59A5ADEE48Q37226576-B4FC1A5E-DAC1-4D75-B6E6-51D227A77AD2Q37396861-41EC5AD7-42BA-49B8-8E43-460C93F8E340Q37595295-3F8371DF-B174-42D3-B28A-AD6C7D479E4BQ37853834-F9E51A48-6BA9-4AFA-84EC-10360A868AEEQ40552294-752476E1-0024-4564-9385-B3AF0DD39BC4Q41813557-47CAC474-6D32-4826-8F39-31E3B0FC52EAQ41957277-F747577A-A87F-4994-A310-98329E0CAAF7Q42137930-6CAF41E6-89D0-44AC-BA1D-B1BED7617B09Q44673709-05DF9AA3-294A-4D06-BE81-0AEFB76528F0Q44954605-522BC1BD-9396-43A4-8508-DAC9415AD924Q46185781-5AFB848E-0708-464A-AB5E-797EC877D56BQ46533470-4939E72C-21C6-44C6-82AF-BEEAC6222767Q46952714-ACC76C20-DF7E-4D23-B478-54578C547883Q48157747-26BFABAD-2F75-4001-A44D-D0CD63DC093EQ52573334-8727A4E9-760B-4D53-8F24-2D180411FFA2Q53087421-1FE96F9C-E2F8-4F0E-98D3-21AA21E7B920Q53276513-DE3A486F-5F52-472B-9D9A-0716C7CC074CQ54624994-F5425089-6ED5-4BC4-9632-B4E640D5254B
P2860
Angiotensin II and its receptors in the diabetic kidney.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiotensin II and its receptors in the diabetic kidney.
@ast
Angiotensin II and its receptors in the diabetic kidney.
@en
Angiotensin II and its receptors in the diabetic kidney.
@nl
type
label
Angiotensin II and its receptors in the diabetic kidney.
@ast
Angiotensin II and its receptors in the diabetic kidney.
@en
Angiotensin II and its receptors in the diabetic kidney.
@nl
prefLabel
Angiotensin II and its receptors in the diabetic kidney.
@ast
Angiotensin II and its receptors in the diabetic kidney.
@en
Angiotensin II and its receptors in the diabetic kidney.
@nl
P356
P1476
Angiotensin II and its receptors in the diabetic kidney.
@en
P2093
P304
P356
10.1053/AJKD.2000.16192
P577
2000-09-01T00:00:00Z